RE: News11 Feb 2025 17:19
KIngHomer,
I am sure lots of things are incoming but not as quickly as investors hoped,
I posted the extracts about the DosemeRx validation the other day, that will be a while before clinicians report back on that.
The PredictONC trial is now expected to happen in Oct-Dec this year.
The trading update states they will meet market expectations due to contracts already signed and that "The Company is actively discussing a number of further contracts although there is no guarantee they will be signed within the current financial year."
There seems to be quite a lag between contract signing, completion of contract and revenue from that, so even if new contracts signed, if they are not signed soon, revenue from these will not be in this year's figures.
A lot of CROs struggled the second part of 2024, clients sat on their hands awaiting the outcomes of elections, etc.
The medical world doesn't move quickly, certainly not to the speed investors want them to.